134 related articles for article (PubMed ID: 19631193)
1. Photolabeling identifies transmembrane domain 4 of CXCR4 as a T140 binding site.
Boulais PE; Dulude D; Cabana J; Heveker N; Escher E; Lavigne P; Leduc R
Biochem Pharmacol; 2009 Dec; 78(11):1382-90. PubMed ID: 19631193
[TBL] [Abstract][Full Text] [Related]
2. Mapping the ligand-binding site on a G protein-coupled receptor (GPCR) using genetically encoded photocrosslinkers.
Grunbeck A; Huber T; Sachdev P; Sakmar TP
Biochemistry; 2011 May; 50(17):3411-3. PubMed ID: 21417335
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical downregulation of CXC chemokine receptor 4 induced by polyphemusin II-derived antagonists.
Masuda R; Oishi S; Tanahara N; Ohno H; Hirasawa A; Tsujimoto G; Yano Y; Matsuzaki K; Navenot JM; Peiper SC; Fujii N
Bioconjug Chem; 2012 Jun; 23(6):1259-65. PubMed ID: 22486464
[TBL] [Abstract][Full Text] [Related]
4. Determination of peptide contact points in the human angiotensin II type I receptor (AT1) with photosensitive analogs of angiotensin II.
Laporte SA; Boucard AA; Servant G; Guillemette G; Leduc R; Escher E
Mol Endocrinol; 1999 Apr; 13(4):578-86. PubMed ID: 10194764
[TBL] [Abstract][Full Text] [Related]
5. Unique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitors.
Choi WT; Tian S; Dong CZ; Kumar S; Liu D; Madani N; An J; Sodroski JG; Huang Z
J Virol; 2005 Dec; 79(24):15398-404. PubMed ID: 16306611
[TBL] [Abstract][Full Text] [Related]
6. Photolabeling identifies position 172 of the human AT(1) receptor as a ligand contact point: receptor-bound angiotensin II adopts an extended structure.
Boucard AA; Wilkes BC; Laporte SA; Escher E; Guillemette G; Leduc R
Biochemistry; 2000 Aug; 39(32):9662-70. PubMed ID: 10933782
[TBL] [Abstract][Full Text] [Related]
7. Identification of residues of CXCR4 critical for human immunodeficiency virus coreceptor and chemokine receptor activities.
Brelot A; Heveker N; Montes M; Alizon M
J Biol Chem; 2000 Aug; 275(31):23736-44. PubMed ID: 10825158
[TBL] [Abstract][Full Text] [Related]
8. Characterization and visualization of [125I] stromal cell-derived factor-1alpha binding to CXCR4 receptors in rat brain and human neuroblastoma cells.
Banisadr G; Dicou E; Berbar T; Rostène W; Lombet A; Haour F
J Neuroimmunol; 2000 Oct; 110(1-2):151-60. PubMed ID: 11024545
[TBL] [Abstract][Full Text] [Related]
9. Distinct functional sites for human immunodeficiency virus type 1 and stromal cell-derived factor 1alpha on CXCR4 transmembrane helical domains.
Tian S; Choi WT; Liu D; Pesavento J; Wang Y; An J; Sodroski JG; Huang Z
J Virol; 2005 Oct; 79(20):12667-73. PubMed ID: 16188969
[TBL] [Abstract][Full Text] [Related]
10. Certification of the critical importance of L-3-(2-naphthyl)alanine at position 3 of a specific CXCR4 inhibitor, T140, leads to an exploratory performance of its downsizing study.
Tamamura H; Omagari A; Hiramatsu K; Oishi S; Habashita H; Kanamoto T; Gotoh K; Yamamoto N; Nakashima H; Otaka A; Fujii N
Bioorg Med Chem; 2002 May; 10(5):1417-26. PubMed ID: 11886804
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.
Zhou N; Luo Z; Luo J; Liu D; Hall JW; Pomerantz RJ; Huang Z
J Biol Chem; 2001 Nov; 276(46):42826-33. PubMed ID: 11551942
[TBL] [Abstract][Full Text] [Related]
12. Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4.
Xu Y; Tamamura H; Arakaki R; Nakashima H; Zhang X; Fujii N; Uchiyama T; Hattori T
AIDS Res Hum Retroviruses; 1999 Mar; 15(5):419-27. PubMed ID: 10195751
[TBL] [Abstract][Full Text] [Related]
13. Recognition of a CXCR4 sulfotyrosine by the chemokine stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12).
Veldkamp CT; Seibert C; Peterson FC; Sakmar TP; Volkman BF
J Mol Biol; 2006 Jun; 359(5):1400-9. PubMed ID: 16725153
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor.
Huang X; Shen J; Cui M; Shen L; Luo X; Ling K; Pei G; Jiang H; Chen K
Biophys J; 2003 Jan; 84(1):171-84. PubMed ID: 12524273
[TBL] [Abstract][Full Text] [Related]
15. Identification by photoaffinity labeling of the extracellular N-terminal domain of PAC1 receptor as the major binding site for PACAP.
Dejda A; Bourgault S; Doan ND; Létourneau M; Couvineau A; Vaudry H; Vaudry D; Fournier A
Biochimie; 2011 Apr; 93(4):669-77. PubMed ID: 21185349
[TBL] [Abstract][Full Text] [Related]
16. Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes.
Tessier S; Boivin S; Aubin J; Lampron P; Detheux M; Fournier A
Biochemistry; 2005 May; 44(21):7844-54. PubMed ID: 15909998
[TBL] [Abstract][Full Text] [Related]
17. Different stereochemical requirements for CXCR4 binding and signaling functions as revealed by an anti-HIV, D-amino acid-containing SMM-chemokine ligand.
Dong CZ; Kumar S; Choi WT; Madani N; Tian S; An J; Sodroski JG; Huang Z
J Med Chem; 2005 Dec; 48(25):7923-4. PubMed ID: 16335916
[TBL] [Abstract][Full Text] [Related]
18. A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.
Zhang WB; Navenot JM; Haribabu B; Tamamura H; Hiramatu K; Omagari A; Pei G; Manfredi JP; Fujii N; Broach JR; Peiper SC
J Biol Chem; 2002 Jul; 277(27):24515-21. PubMed ID: 11923301
[TBL] [Abstract][Full Text] [Related]
19. Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes.
Tamamura H; Omagari A; Oishi S; Kanamoto T; Yamamoto N; Peiper SC; Nakashima H; Otaka A; Fujii N
Bioorg Med Chem Lett; 2000 Dec; 10(23):2633-7. PubMed ID: 11128640
[TBL] [Abstract][Full Text] [Related]
20. A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.
Tamamura H; Xu Y; Hattori T; Zhang X; Arakaki R; Kanbara K; Omagari A; Otaka A; Ibuka T; Yamamoto N; Nakashima H; Fujii N
Biochem Biophys Res Commun; 1998 Dec; 253(3):877-82. PubMed ID: 9918823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
